Matches in SemOpenAlex for { <https://semopenalex.org/work/W2181124388> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2181124388 endingPage "734" @default.
- W2181124388 startingPage "724" @default.
- W2181124388 abstract "Aim The aim of the present study was to analyse concomitant drug use and its association with outcome in patients ( N = 17 701) receiving rivaroxaban or standard of care (SOC) for the prevention of venous thromboembolism after major orthopaedic surgery in the non‐interventional, phase IV XAMOS (Xarelto® in the prophylaxis of post‐surgical venous thromboembolism after elective major orthopaedic surgery of hip or knee) study. Methods Concomitant drug use was at the discretion of the treating physician. Prespecified co‐medications of interest were cytochrome P450 (CYP) 3A4/P‐glycoprotein inhibitors/inducers, platelet aggregation inhibitors (PAIs) and nonsteroidal anti‐inflammatory drugs (NSAIDs). Crude event incidences were compared between rivaroxaban and SOC groups. Results CYP3A4/P‐glycoprotein inhibitor/inducer use was infrequent, in contrast to PAI (~7%) and NSAID (~52%) use. Rivaroxaban was associated with a lower incidence of overall symptomatic thromboembolic events compared with SOC, regardless of co‐medication use. In both treatment groups, PAI users, with higher age and prevalence of cardiovascular co‐morbidities, had similar higher (>7‐fold) incidences of symptomatic arterial but not venous thromboembolic events compared with non‐users. NSAID use had no influence on thromboembolic events. However, odds ratios (ORs) for major bleeding events ( European Medicines Agency definition) were higher in NSAID users compared with non‐users in rivaroxaban [OR = 1.50; 95% confidence interval (CI) 1.06, 2.13] and SOC (OR = 1.70; CI 1.16, 2.49) groups. In PAI users, ORs for major bleeding events were no different from those of non‐users in both the rivaroxaban (OR = 1.49; CI 0.84, 2.65) and SOC (OR = 1.46; CI 0.82, 2.62) groups. Conclusions Use of NSAIDs in XAMOS was frequent and associated with a higher frequency of bleeding events in patients receiving rivaroxaban or SOC, although the benefit–risk profile of rivaroxaban compared with SOC was maintained." @default.
- W2181124388 created "2016-06-24" @default.
- W2181124388 creator A5005370327 @default.
- W2181124388 creator A5009167101 @default.
- W2181124388 creator A5039623492 @default.
- W2181124388 creator A5041329419 @default.
- W2181124388 creator A5086575517 @default.
- W2181124388 creator A5090494524 @default.
- W2181124388 creator A5091895035 @default.
- W2181124388 date "2016-02-12" @default.
- W2181124388 modified "2023-10-05" @default.
- W2181124388 title "Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions" @default.
- W2181124388 cites W1564607482 @default.
- W2181124388 cites W1839975480 @default.
- W2181124388 cites W1998134066 @default.
- W2181124388 cites W2008333987 @default.
- W2181124388 cites W2013750247 @default.
- W2181124388 cites W2014491911 @default.
- W2181124388 cites W2027710857 @default.
- W2181124388 cites W2036506340 @default.
- W2181124388 cites W2047431135 @default.
- W2181124388 cites W2135583595 @default.
- W2181124388 cites W2135700027 @default.
- W2181124388 cites W2138247049 @default.
- W2181124388 cites W2150567120 @default.
- W2181124388 cites W2151252098 @default.
- W2181124388 cites W2155155275 @default.
- W2181124388 cites W2731852166 @default.
- W2181124388 doi "https://doi.org/10.1111/bcp.12836" @default.
- W2181124388 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4799939" @default.
- W2181124388 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26580706" @default.
- W2181124388 hasPublicationYear "2016" @default.
- W2181124388 type Work @default.
- W2181124388 sameAs 2181124388 @default.
- W2181124388 citedByCount "15" @default.
- W2181124388 countsByYear W21811243882016 @default.
- W2181124388 countsByYear W21811243882017 @default.
- W2181124388 countsByYear W21811243882018 @default.
- W2181124388 countsByYear W21811243882020 @default.
- W2181124388 countsByYear W21811243882021 @default.
- W2181124388 countsByYear W21811243882022 @default.
- W2181124388 countsByYear W21811243882023 @default.
- W2181124388 crossrefType "journal-article" @default.
- W2181124388 hasAuthorship W2181124388A5005370327 @default.
- W2181124388 hasAuthorship W2181124388A5009167101 @default.
- W2181124388 hasAuthorship W2181124388A5039623492 @default.
- W2181124388 hasAuthorship W2181124388A5041329419 @default.
- W2181124388 hasAuthorship W2181124388A5086575517 @default.
- W2181124388 hasAuthorship W2181124388A5090494524 @default.
- W2181124388 hasAuthorship W2181124388A5091895035 @default.
- W2181124388 hasBestOaLocation W21811243881 @default.
- W2181124388 hasConcept C120665830 @default.
- W2181124388 hasConcept C121332964 @default.
- W2181124388 hasConcept C126322002 @default.
- W2181124388 hasConcept C156957248 @default.
- W2181124388 hasConcept C2776301958 @default.
- W2181124388 hasConcept C2777628954 @default.
- W2181124388 hasConcept C2778661090 @default.
- W2181124388 hasConcept C2778810321 @default.
- W2181124388 hasConcept C2779161974 @default.
- W2181124388 hasConcept C2779384505 @default.
- W2181124388 hasConcept C44249647 @default.
- W2181124388 hasConcept C61511704 @default.
- W2181124388 hasConcept C71924100 @default.
- W2181124388 hasConceptScore W2181124388C120665830 @default.
- W2181124388 hasConceptScore W2181124388C121332964 @default.
- W2181124388 hasConceptScore W2181124388C126322002 @default.
- W2181124388 hasConceptScore W2181124388C156957248 @default.
- W2181124388 hasConceptScore W2181124388C2776301958 @default.
- W2181124388 hasConceptScore W2181124388C2777628954 @default.
- W2181124388 hasConceptScore W2181124388C2778661090 @default.
- W2181124388 hasConceptScore W2181124388C2778810321 @default.
- W2181124388 hasConceptScore W2181124388C2779161974 @default.
- W2181124388 hasConceptScore W2181124388C2779384505 @default.
- W2181124388 hasConceptScore W2181124388C44249647 @default.
- W2181124388 hasConceptScore W2181124388C61511704 @default.
- W2181124388 hasConceptScore W2181124388C71924100 @default.
- W2181124388 hasIssue "4" @default.
- W2181124388 hasLocation W21811243881 @default.
- W2181124388 hasLocation W21811243882 @default.
- W2181124388 hasLocation W21811243883 @default.
- W2181124388 hasOpenAccess W2181124388 @default.
- W2181124388 hasPrimaryLocation W21811243881 @default.
- W2181124388 hasRelatedWork W1568966348 @default.
- W2181124388 hasRelatedWork W2013904527 @default.
- W2181124388 hasRelatedWork W2116384196 @default.
- W2181124388 hasRelatedWork W2148773563 @default.
- W2181124388 hasRelatedWork W2515183968 @default.
- W2181124388 hasRelatedWork W2554174230 @default.
- W2181124388 hasRelatedWork W2582505536 @default.
- W2181124388 hasRelatedWork W2609267468 @default.
- W2181124388 hasRelatedWork W2779906290 @default.
- W2181124388 hasRelatedWork W1570353559 @default.
- W2181124388 hasVolume "81" @default.
- W2181124388 isParatext "false" @default.
- W2181124388 isRetracted "false" @default.
- W2181124388 magId "2181124388" @default.
- W2181124388 workType "article" @default.